Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases
Pei Shen, Yezhi Wang, Xiangxiang Jia, Pengfei Xu, Lian Qin, Xi Feng, Zhiyu Li, Zhixia Qiu
Topics & Concepts
Janus kinaseJAK-STAT signaling pathwayRuxolitinibCancer researchSykTofacitinibstatTyrosine kinase 2Tyrosine kinaseSTAT proteinKinaseSTAT3Signal transductionImmune systemImmunologyMedicineBiologyReceptorCell biologyPlatelet-derived growth factor receptorGrowth factorInternal medicineBone marrowMyelofibrosisRheumatoid arthritisAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment